Health
Saudi Arabia to begin human trials with CanSino’s Covid-19 vaccine – TRT World
Researchers say CanSino’s vaccine which is co-developed with China’s military research unit, appears to be safe and induced immune responses in most subjects.
Researchers say CanSino’s vaccine which is co-developed with China’s military research unit, appears to be safe and induced immune responses in most subjects.
Chinese vaccine maker CanSino Biologics’ sign is pictured on its building in Tianjin, China November 20, 2018.
(Reuters)
Saudi Arabia will soon begin Phase
III clinical trials on around 5,000 people for a Covid-19
vaccine developed by China’s CanSino Biologics Inc.
Last month, CanSino’s co-founder said the company was in
talks with…
-
Business18 hours agoWhy Vault Minerals, Droneshield, Westgold Resources shares are climbing higher today
-
General23 hours agoBrick portico a relic of ‘prestigious’ Horton College in northern midlands
-
Noosa News20 hours agoQueenslanders to continue legal challenges against COVID-19 directives after successful appeal
-
Noosa News13 hours agoRacing Queensland responds to criticism of ‘deadliest’ greyhound track